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ABSTRACT 
 
The research aimed to investigate secretion, expression and location of IL-17 relative 
ligands, IL-17 relative receptors, infiltrating inflammatory cells and parenchymal 
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structural cells in colorectal cancer (CRC) compared with ulcerative colitis (UC) and 
benign hyperplastic polyp. 29 human intestinal tissues with CRC, 17 with UC and 7 
with polyp were stained using immunohistochemistry to evaluate immunoreactivity 
for IL-17 family relative ligands including IL-17A, E, F and their respective relative 
receptors such as IL-17RA, IL-17RB and IL-17RC. At the same time the infiltration 
of inflammatory cells including lymphocytes, phagocytes, mast cells and neutrophils 
and parenchymal structural cell changes involving vascular endothelial cells and 
CD90+ fibroblast cells were also evaluated using the same methods. The 
immunoreactivity or positive inflammatory cells of all the sections were analyzed 
using professional image analysis software to determine statistical significance. The 
immunoreactivity for IL-17A, IL-17RA, IL-17E, IL-17RB and IL-17F showed 
significant decrease in CRC tissue when compared to UC (p = 0.00001. respectively). 
The reduction of above IL-17 relative ligands and receptors was accompanied by an 
obvious decrease in the number of infiltrating neutrophils and mast cells in CRC (p = 
0.00001 and p = 0.007, respectively) but accompanied by a marked increase of CD31+ 
blood vessels (p = 0.001). The immunoreactivity of IL-17A, IL-17RA, IL-17E, 
IL-17RB and IL-17F and the numbers of infiltrating neutrophils and mast cells 
showed significant decrease in CRC tissues when compared to those in polyp (p < 
0.05). In contrast, the immunoreactivity of IL-17RC and the numbers of CD3+ 
1ymphocytes were elevated in CRC when compared with those in polyp (p = 0.0001, 
p = 0.007, respectively). In CRC tissues, positive correlations between IL-17A, 
IL-17RA with CD68+ macrophages were observed respectively (r = 0.621, p = 0.0001; 
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r = 0.75, p = 0.0001). IL-17 cytokine family including ligands and their corresponding 
receptors were secreted and expressed by infiltrating inflammatory cells. Not only 
infiltrating lymphocytes but also increased blood endothelial cells were relative 
significantly to genesis and progression of CRC. 
 
Keywords: IL-17 cytokine family, colorectal adenocarcinoma, ulcerative colitis, 
inflammatory cell, structural cell. 
 
1. Introduction 
 
    In worldwide, colorectal cancer (CRC) is among the top three causes of cancer 
related death in men and women. According to the statics, there are about 50,000 
patients died from CRC each year. Sessile serrated adenomas/polyps and ulcerative 
colitis (UC) are recognized as risk factor for CRC especially of larger, multiple or 
familial polyps and chronic UC [1-3]. The pathogenesis of UC, polyp and CRC is not 
very clear, but many factors especially cytokines and inflammatory mediators are 
related to the occurrence and development of those intestinal diseases. Previous 
research showed that cytokine family such as IL-17 ligands and their receptors signals 
participated in occurrence and development of those diseases [4, 5].  
    The IL-17 family plays important roles in solid tumor research involving prostate 
cancer, bladder cancer, lung cancer and glioma etc and becomes one of the hot spots 
in recent years. IL-17 family is consists of six ligands including interleukin 17 
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(IL-17A) interleukin 17B (IL-17B), interleukin 17C (IL-17C), interleukin 17 D 
(IL-17D), interleukin 17E, (IL-17E) and interleukin 17F (IL-17F) and their respective 
relative receptors IL-17RA, IL-17RB, IL-17RC, IL-17RD and IL-17RE, which share 
sequence homology like their ligands. The binding of ligands and their receptors 
affect the gene expression of downstream trough complex pathways, which can 
produce different biological effects. Among all of the IL-17 family ligands, IL-17A 
and IL-17E are the most concerned cytokines because they share opposite biological 
functions in the field of solid tumor [6, 7]. In addition, IL-17F has also become 
research hotpot because it has high molecular homology with IL-17A and possess 
similar functions to IL-17A especially in tumor field [6]. The collected data confirmed 
that IL-17A mainly connected with its receptor IL-17RA and IL-17E mainly binds to 
its receptor IL-17RB to produce different biological functions in malignant tumor 
fields. IL-17F can also bind to IL-17RA or IL-17RC to regulate the expression of its 
downstream genes which promotes tumor formation or progression like 
IL-17A-IL-17RA signal [8]. Because of high degree homology, IL-17A and IL-17F 
share similar functions and are main pro-inflammatory cytokines in inflammatory 
intestinal diseases and malignant tumors [9]. While IL-17E (also called IL-25) which 
has relatively low homologous sequences with IL-17A and IL-17F integrates with its 
own receptor exerting significant biological effect in asthma and atopic diseases [10]. 
In addition, IL-17E has been proved to inhibit human melanoma xenograft growth in 
vivo[11].              
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    Previous studies have reported IL-17A, IL-17F and other cytokines are produced 
and secreted mainly by monocytes (including Th17 lymphocytes, macrophage and 
eosinophils, etc.) and secondly by structural cells (such as smooth muscle and 
endothelial cells). Those cytokines contribute to the pathogenesis of UC and CRC 
[4,12], however, we do not know the expression location and expression amount of 
IL-17 family cytokines, the infiltrating numbers of inflammatory cells and the 
changes of structural cells in CRC, benign polyp and UC. We also don’t know 
whether there is a correlation between IL-17 family cytokines with occurrence and 
progression of intestinal diseases. So we systematically compared immunoreactivity 
of IL-17 family ligands and their relative receptors, infiltrating inflammatory cells and 
structural cells using immunohistochemistry in those tissues from polyp, UC and CRC. 
In order to explore the relationship between those diseases and above indicators, we 
analyzed correlations between IL-17 family cytokines themselves, the infiltrating 
inflammatory cells and the changes of structural cells with IL-17 family cytokines in 
CRC.  
 
2. Materials and methods 
 
2.1. Patients and specimens 
The written informed consents were obtained from the First Hospital of Jilin 
University (NO. JL20130218), the Affiliated Hospital of Beihua University (NO. 
BH20130014) and the People's Hospital of Jilin City (JLS2013006), Jilin Province, 
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People’s Republic of China, from January 2011 to December 2013. We obtained 
human colon specimens from methods to processes in accordance with the Medical 
Ethical Principles Involving Human Subjects, which were formulated in the World 
Medical Association Declaration of Helsinki (revised in 2008). The blocks included 
29 patients with colorectal adenocarcinomas, 17 patients with UC and 7 patients with 
colorectal hyperplastic polyps. All of the patients with adenocarcinomas, 26 tumors 
were carried out surgical resection and 3 tumors were endoscopical biopsy and the 
other intestinal tissues were endoscopical biopsy. Serial tissue sections with 4μm 
were cut for each patient sample. The first serial section was stained for H& E, and 
the diagnostic criteria were described as previously [13-15]. The remaining sections 
were stained with specific antibodies using Immunohistochemical staining. The 
summary of patients and clinical data were showed in Table 1. 
 
2.2. Immunohistochemistry  
 
    All the tissue slides were stained with a similar protocol as previously described 
[16]. Antigen retrieval was realized under high temperature and high pressure with 
sodium citrate solution (PH=6). Endogenous peroxidase activity was inhibited using 
hydrogen peroxide in methanol (0.3%) at room temperature for half an hour. Slides 
were washed with PBS and then blocked with 2.5% horse serum blocking buffer 
(Vector Laboratories, Cat# S-2012) for 20 minutes, and then with dilution buffer with 
goat serum (5%) for 30 minutes. All washes and blocking steps were at room 
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temperature. We observed the secretion, expression and location for IL-17 family 
relative cytokines, inflammatory cells (such as neutrophysils, lymphocytes, 
macrophages and mast cells) and structural cells (for example CD90
+ 
fibroblasts and 
vascular endothelial cells) as previously described [16]. We used the specific 
antibodies, which were against CD3 (lymphocyte), CD68 (macrophage), elastase 
(neutrophil), tryptase (mast cell), CD31 (mainly vascular endothelial cell) and CD90 
(mainly fibroblast) (Table 2) to identify infiltrating inflammatory cells and 
parenchymal structural cell types. Specific information about primary antibody and 
their optimal dilutions are summarized in Table2. We used DAB kit 
(diaminobenzidine, ZhongShan Golden Bridge Biological Company, Beijing, China) 
to detect positive signals.  
All the slides with immunohistochemical staining including IL-17 family relative 
ligands and receptors, CD90
+ 
fibroblasts, infiltrating inflammatory cells and CD31
+ 
blood vessel were scanned at 10×magnification using an Olympus microscope. 
These images were exported as TIFF files and uploaded into Image Pro Plus 6.0 
software (Media Cybernetics, Maryland, USA). Separate investigators were 
proficiency in the software applications and absolutely agreed with manual hand 
counts. The positive signals were quantified as the percentage staining of the total 
stainable area of the sections for IL-17 family cytokines and CD90
+ 
cells by the 
haematoxylin counterstaining, while infiltrating inflammatory cells and CD31
+ 
blood 
vessels were quantified as the numbers of cells per unit area of the entire sections as 
before [16].  
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2.3. Statistical analysis 
 
    Data were analyzed using a commercially available statistical package (Minitab 
for Windows, Minitab Release 9.2; Minitab, Inc, State College, PA) provided by Dr. 
Sun Ying. Differences between groups were analyzed using Kruskal-Wallis test 
followed by the Mann-Whitney U test. Data are presented n the figures as the mean ± 
SEM. A p value of less than 0.05 was considered statistically significant. The 
correlation between IL-17 family relative cytokines with inflammatory cells and 
structural cells was performed using a non –parametric Spearman correlation.  
 
3. Results 
 
3.1. Secretion and expression of IL-17A and its receptor IL-17RA in 
intestinal tissues 
 
    The IHC results indicated that IL-17A immunoreactivity was significantly higher 
in UC and polyp samples compared with CRC (Fig 1A-B, p = 0.00001 and p = 0.001, 
respectively). In addition, its expression amount was significantly higher in polyp 
samples compared with UC samples (p = 0.012). Mononuclear cells in interstitium, 
glandular epithelium, vascular endothelial cells and some malignant cells could secret 
IL-17A.  
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The IHC results indicated that IL-17RA expression amount was also significantly 
higher in UC and polyp samples compared with CRC (Fig 1C-D, p = 0.0001 and p = 
0.001, respectively), while there was no significant statistical difference between UC 
and polyp samples (p = 0.567). The expression amount of IL-17RA immunoreactivity 
was similar to IL-17A (Fig 1C-D), which was also predominantly expressed in 
mononuclear cells in interstitium, glandular epithelium, vascular endothelial cells as 
well as some malignant cells. 
 
3.2. Secretion and expression of IL-17E and its receptor IL-17RB in 
intestinal tissues 
 
Our results indicated that IL-17E located mainly in non-tumor tissues and cells. 
In UC and polyps samples IL-17E immunoreactivity was significantly higher 
compared with CRC (Fig 2A-B, p = 0.00001 and p = 0.0005, respectively). While 
there was no obvious differences for IL-17E immunreactivity between UC and polyp 
samples (Fig 2A-B，p = 0.998). IL-17E immunoreactivity mainly located in 
mononuclear cells in interstitium, glandular epithelium and some vascular endothelial 
cells.  
IL-17RB, the receptor of IL-17E, was secreted by mononuclear cells, epithelial 
cells and vascular endothelial cells (Fig 2C). Its immunoreactivity was higher in UC 
samples compared with polyp (p = 0.022) and CRC (p = 0.00001) (Fig 2C-D). 
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Compared with CRC samples, IL-17RB expression amount in polyp samples was also 
significantly elevated (p = 0.0001).  
 
3.3. Secretion and expression of IL-17F and its receptor IL-17RC in 
intestinal tissues 
 
    Our IHC results showed that positive IL-17F was significantly higher in UC and 
polyp samples compared with CRC (Fig 3A-B, p = 0.00001 and p = 0.0007, 
respectively), but there was no significant difference for IL-17F immunoreactivity 
between UC and polyp samples (Fig3A-B, p = 0.423). Similar to IL-17A and IL-17E, 
IL-17F was secreted principally by mononuclear cells, epithelium, vascular 
endothelial cells as well as some malignant cells (Fig 3A).    
Previous research data indicated that IL-17F not only combines with IL-17RA 
but also with IL-17RC to produce biological effect, so we detected IL-17RC 
expression amount in all the intestinal samples. Our research results indicated that 
IL-17RC was expressed on mononuclear cells, epithelium, vascular endothelial cells 
and some malignant cells in CRC (Fig 3C). Its immunoreactivity was significantly 
reduced in polyp compared with UC (p = 0.003) and CRC (p = 0.0001), while no 
significant difference was observed between UC and CRC samples (p = 0.195).  
 
3.4. Infiltration of T lymphocytes and macrophages in intestinal 
tissues 
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    CD3+ cells, as the marker for lymphocytes, infiltrated mainly in interstitium of 
UC, polyp and CRC. Compared with polyp, the number of cells stained with this 
cellular marker was higher in both UC (p = 0.019) and CRC (p = 0.007) (Fig 4A-B), 
while there was no significant difference in number of positive cells in UC and CRC 
(p = 0.792).  
CD68+ cells, as the marker for macrophages, infiltrated mainly in interstitium. 
Through analysis, there were not obvious differences in number of CD68+ positive 
cells among the three groups (Fig 4C-D, UC vs CRC: p = 0.776; polyp vs CRC: p = 
0.110, and UC vs polyp: p = 0.168, respectively). 
 
3.5. Infiltration of neutrophils and mast cells in intestinal tissues 
 
    Because under ordinary circumstances, a large number of E. coli bacteria grow in 
the gut, we also detected other related inflammatory cells infiltration. Elastase+ 
neutrophils and tryptase+ mast cells were detected in the sections from UC, polyp and 
CRC through IHC staining. The results showed both neutrophils and mast cells 
infiltrated mainly in interstitium. In UC tissues the median number of neutrophils was 
higher compared with polyp and CRC (Fig5A-B, p = 0.01 and p = 0.00001, 
respectively), while we did not observe significant differences in number of 
neutrophils between polyp and CRC (p = 0.615).  
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The median numbers of mast cells per unit area of the sections in UC and polyp 
were significantly higher than that in CRC (Fig 5 C-D, p = 0.007 and p = 0.001, 
respectively), while no significant differences in number of mast cells were seen 
between polyp and UC (p = 0.427) (Fig5C-D). 
 
3.6. Changes in structural cells in intestinal tissues 
 
    As we know IL-17 family cytokines were secreted and expressed not only by 
monocytes (lymphocytes, phagocytes, neutrophils and mast cells) but also by other 
parenchymal cells (e.g vascular endothelial cells and glandular epithelium etc), so we 
detected parenchymal cell changings including vascular endothelial cells and CD90+ 
fibroblast cells. The number of CD31+ vascular endothelial cells increased in polyp 
and CRC compared with UC (Fig 6A-B, p = 0.0001, p = 0.001), we did not observe 
significant differences in number of blood vessels between polyp and CRC samples (p 
= 0.12).  
CD90+ cells, as the marker of fibroblast, were slightly elevated in CRC 
compared with UC and polyp, but no significant differences of fibroblasts were seen 
among the three groups (Fig 6C-D).  
 
3.7. Correlation of IL-17 family relative ligands and receptors, 
inflammatory cellular infiltration and parenchymal cells changes in 
CRC 
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The Pearson correlation method was used to determine the association between 
immunoreactivity for the IL-17 family ligands and their receptors, inflammatory cells 
and parenchymal cells in CRC. The obvious positive correlation was observed 
between IL-17A with its own receptor IL-17RA (Fig 7A, r = 0.553, p = 0.02); but 
unfortunately, the correlations between IL-17E with its receptor IL-17RB, IL-17F 
with its receptor IL-17RC were not identified. Furthermore, the associations 
between the numbers of CD68+ macrophages in CRC tissues were consistent with 
IL-17A (Fig 7B r = 0.621, p = 0.001) and IL-17RA (Fig 7C, r = 0.75, p = 0.001) 
respectively, which indicated that IL-17A and IL-17RA were mainly secreted and 
expressed by macrophages. 
 
4. Discussion 
 
    Inflammation especially during chronic infection predisposes to cancer initiation 
and development. In CRC, the imbalance of T helper 1/T helper 2 immune response 
induces cell proliferation and leads to phenotype change of immune cells in the tumor 
microenvironment, then a large number of abnormal cytokines will be synthesized 
and released [17]. During all the cytokines, IL-17 family has become a hot spot of 
tumor research. In our previous research, we have known that IL-17 family relative 
cytokines participate in the pathogenesis and the progression of benign prostatic 
hyperplasia and prostate cancer [16]. The collected data proved that IL-17 family may 
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UC, polyp and CRC [18-19]，but there has no systematically compared study of the 
IL-17 family relative cytokines (IL-17A, IL-17E, IL-17F , IL-17RA, IL-17RB and 
IL-17RC in these common intestinal disorders till now. In this present study, we 
analyzed the expression and location of IL-17 family relative ligands and their 
respective receptors from patients with UC, polyp and CRC in these intestinal tissues. 
Because IL-17 family relative cytokines are secreted and expressed by both 
mononuclear cells and parenchyma cells, we also simultaneously detected relative 
inflammatory cells quantity and location, parenchymal structural changes and 
angiogenesis in order to carry out research of cellular and animal level experiments in 
the near future. 
    Because a large number of bacteria live in the intestinal environment, pervasive 
inflammatory cells (lymphocyte, phagocyte, neutrophysil and mast cell, etc.) 
infiltration is a typical feature in intestinal tract. From our histological tissues we 
confirmed that more monocytes infiltrated in UC and CRC slides. Such severe 
infiltration of many inflammatory cells could trigger effective and specific 
inflammatory response, which conversely synthesizes and eliminates more abnormal 
cytokines and humoral factors. These abnormal cytokines and humoral factors have 
double-faced effects, which make further efforts to induce more severe inflammation 
response, tissue damage even tumorigenesis, tumor growth and metastasis[20]. 
Therefore, through effective methods to reduce inflammatory cell infiltration and 
subsequent inflammatory response in intestinal tissues will play an important role in 
prevention and treatment of cancer.  
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    Our data revealed that the secretion of IL-17A/E/F ligands and the expression of 
their corresponding receptors IL-17RA/RB/RC increased obviously in UC compared 
with CRC (Fig 1-3) with distinct infiltration of neutrophils and mast cells between UC 
and CRC simultaneously (Fig 5), which means that the infiltration of neutrophils and 
mast cells have some relationship with IL-17 family relative cytokines. From our 
previous research tissues in prostatic and present data in intestinal tissues we knew 
that elevated IL-17A/E/F and their receptors contributed to more inflammatory cells 
infiltration, then these inflammatory cells secreted more cytokines and humoral 
factors (including IL-17 family ligands and receptors) to cause further inflammation 
response in intestinal tract. This is a typical positive feedback process. These elevated 
abnormal cytokines may promote the aberrant cellular proliferation associated with 
polyp and CRC generation. But the exact mechanism should be investigated further. 
    Through comparative analysis we knew that secretions of IL-17A/E/F and their 
expressions of receptors were markedly reduced in CRC compared with UC and 
polyp besides IL-17CR (Fig 1-3). Perhaps mononuclear cells such as lymphocytes, 
phagocytes, mast cells, neutrophils and eosinophiles and other structural cells such as 
smooth muscles and glandular epithelial cells synthesized and secreted IL-17 relative 
family cytokines. In our histological sections, more inflammatory cells infiltrate in 
UC tissue and a large amount of glandular epithelial cells proliferate in polyp tissue, 
while In CRC tissue the mononuclear cells (especially neutrophysils and mast cells) 
were lower (Fig 5) which explained the intrinsic link between them partly. 
Additionally, IL-17RC expression was elevated with damaged and/or abnormal 
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structural cells in CRC, which indicated that colorectal cancer cells can expressed 
IL-17C and participated in the pathogenesis of colorectal cancer with unknown 
pathways. Both IL-17A and IL-17F can combine with IL-17RC to induce biological 
responses, while IL-17F is rather important although we are not clear of it and its 
receptor IL-17RC in the pathogenesis of CRC. The collected data showed IL-17F can 
provoke angiogenesis because elevated microvessel density in turn contribute to 
IL-17A or IL-17F production and release [21]. IL-17A and IL-17F are cytokines with 
strong proinflammatory effects and their increased expression are often found in 
malignant tumors [22-24]. The positive feedback cycle in intestinal tissues will 
promote cancerous cell proliferation even metastasis. Interestingly, the secretion of 
IL-17F decreased but the expression of IL-17RC increased in CRC compared with 
UC and polyp in our study, suggesting that IL-17F and IL-17RC are possibly secreted 
and expressed not by single cell population. Until far, there is lack of study 
investigating whether malignant cells can express more IL-17F receptor in CRC 
although it has been shown that the IL-17F genetic polymorphisms correlate with the 
risk of CRC in Chinese people [25]. The functions of IL-17F-IL-17RC signal in 
intestinal tumor microenvironment are complex and their relationship with CRC has 
not been elucidated yet. But targeting IL-17F or IL-17RC using different methods 
might provide a new treatment for CRC. In order to figure out the roles of IL-17 
relative family cytokines on intestinal relative diseases, further experiments are 
needed to perform in vivo and in vitro.  
    Previous studies have demonstrated that IL-17A and IL-17F positive cells are 
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frequently present in CRC. Both IL-17A and IL-17F have the properties to promote 
occurrence and progression of malignancy when combined with their receptors, while 
IL-17E has different properties and acts on a distinct receptor IL-17RB, as well as 
IL-17RA to exert anti melanoma effects [26].  Al-Samadi A et al showed that IL-17B 
was increased in CRC with a strong presence both in the epithelial and stromal 
compartments, IL-17C showed different expression depending on the grade of 
differentiation and IL-17E remained unchanged compared to healthy colons. In 
contrast, IL-17F was decreased in CRC [27]. In the present study, IL-17E increased in 
both UC and polyp but reduced in CRC. Our research results indicated that IL-17E 
also participated in the pathogenesis of UC and polyps. IL-17E might involve in the 
inflammation response through acting on its receptor IL-17BR or IL-17RA expressed 
on mononuclear cells such as lymphocytes, phagocytes and mast cells or structural 
cells such as fibroblast cells, smooth muscles and blood vessels then resulting in 
different degrees of inflammation and changings of structural cells [3,10,13,26]. On 
the other hand, we observed that IL-17E and receptor (IL-17RB) decreased in CRC 
samples (Fig 2). The expression of IL-17RB in CRC also decreases, which indicates 
that the infiltration of mononuclear cells is less since these cells can also secret and 
release IL-17RB [13]. On the other hand the results suggest that IL-17E-IL-17RB 
signal transduction plays anti tumor role in CRC. If there are any, the details and 
underlying mechanisms of IL-17E signal in the pathogenesis of CRC should be 
explored and targeting this signal through different methods will create satisfactory 
biological effects.  
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    Angiogenesis plays a significant role in the development and spread of colorectal 
cancer and has been recognized as a prognostic marker in a variety of human 
neoplasms [28]. More vascular endothelial cells were observed in CRC and polyp 
compared with UC from these intestinal tissues (Fig 6). As we know that adequate 
blood supply is one of the essential conditions for tumor survival. More angiogenesis 
with adequate blood is a very important link from tumor growth, progression to 
metastasis in CRC, because cancer cells need more blood supplying compared with 
normal or benign tumor to sustain its abnormal cell proliferation, conversely these 
cancerous cells and elevated angiogenesis might promote other cell aberrant 
proliferation and induce changes in tumor microenvironment. This possibly explains 
at least in part the reason why the number of CD31+ blood vessels increased and 
numbers of monocytes such as neutrophysils and mast cells decreased in CRC.  
    Inflammatory cell infiltration is one of the typical characteristics of the intestinal 
tract especially in UC, while IL-17 family cytokines closely link with inflammation. 
Although IL-17A is a weak NF-κB activator, when synergize with other cytokines like 
TNF-α it can promote and prolong pro-inflammatory responses [22]. We accordingly 
detected inflammatory cell types through immunohistochemistry staining with 
different specific antibodies in our study. Tumor-infiltrating lymphocytes are the 
main actors in suppressing and controlling the host immune response to tumor 
cells. However, the detailed regulatory mechanisms remain to be elucidated.  
    Inflammatory infiltration is typical characteristics in intestinal relative diseases. 
Our research showed that he numbers of CD3+ T lymphocytes and CD68+ macrophage 
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increased in UC and CRC tissues (Fig 4), which suggests that these cells might 
involve in occurrence and development process of UC and CRC. Again, macrophage 
is an essential component of tumor microenvironment and plays an important role in 
tumor progression especially tumor-associated macrophages. Macrophage has 
promoting or inhibiting tumor dual function in different tumor types [29]. So the 
function of macrophage is very complex and should be elucidated in the following 
research. The increased infiltrating macrophages in UC and CRC were significantly 
higher compared with polyp, which indicated that these macrophages might play an 
important role through secreting different numbers of cytokines or humoral factors in 
enteritis genesis and in CRC progression.  
    In present study, we observed that IL-17A has positive correlation with its 
receptor IL-17RA in CRC (Fig 7), simultaneously, both markers were also positively 
associated with CD68+ macrophages (Fig 7), which suggested that IL-17A and 
IL-17RA were mainly synthetized and secreted by CD68+ macrophages. Significances 
of such pathways of IL-17A and its receptor IL-17RA on macrophages in CRC should 
be further discussed in the following research. 
    Although we have done a series of comparative research in IL-17 family 
cytokines, inflammatory cells infiltration and parenchymal cells changings in 
intestinal tissues, there exists some limitations in present study. Firstly, we have not 
collected the complete normal samples, and the samples from patients were not 
enough, which make the conclusion questionable. Secondly, despite 
immunohistochemistry staining was applied to detect specific antigen expression and 
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location in UC, polyp and CRC pathological tissues, we do not know for certain if this 
method is accurate because it is not so specific. Finally, the specimens were obtained 
through endoscopic biopsy or resection in our study, which has some limitations. All 
of these may bias to verify the results. 
    In summary, our data suggest that IL-17 family cytokines may participate in the 
pathogenesis of CRC and other intestinal disorders such as UC and polyp in distinct 
pathways. Inflammatory cells infiltration and structural changings all promote 
occurrence and progression in CRC as well as UC and polyp. Targeting or promoting 
these cytokines or inflammatory cells may provide alternative therapeutic benefits for 
clinic treatment.  
In summary, our research data suggest that infiltrating inflammatory cells 
especially phagocytes might be associated with IL-17A and IL-17RA, while 
infiltration of lymphocytes and increased blood endothelial cells might be associated 
with CRC occurrence and development.  
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Figure Legends    
 
Figure. 1. Secretion and expression of IL-17A and IL-17RA in UC, polyp and 
CRC tissues. A: The staining with the marker for IL-17A in intestinal sections from 
subjects with ulcerative colitis (UC, n = 17), polyp (n = 7) and colorectal cancer (CRC, 
n = 29) (original magnification x 10 and 20, Arrows representing positive staining). B: 
Quantitative analysis of IL-17A positive area of intestinal sections (% of whole 
sections). C：The staining with the marker for IL-17RA in intestinal sections from UC, 
polyp and CRC (original magnification x 10 and 20, Arrows representing positive 
staining). D: Quantitative analysis of IL-17RA positive area of intestinal sections (% 
of whole sections). Data are expressed as the mean ± SEM.  
 
Figure. 2. Secretion and expression of IL-17E and IL-17RB in UC, polyp and 
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CRC tissues. A: The staining with the marker for IL-17E in intestinal sections from 
subjects with ulcerative colitis (UC, n = 17), polyp (n = 7) and colorectal cancer (CRC, 
n = 29) (original magnification x 10 and 20, Arrows representing positive staining).  
B: Quantitative analysis of IL-17E positive area of intestinal sections (% of whole 
sections). C: The staining with the marker for IL-17RB in intestinal sections from UC, 
polyp and CRC (original magnification x 10 and 20, Arrows representing positive 
staining). D: Quantitative analysis of IL-17RB positive area of intestinal sections (% 
of whole sections). Data are expressed as the mean ± SEM.  
 
Figure. 3. Secretion and expression of IL-17F and IL-17RC in UC, polyp and 
CRC tissues. A: The staining with the marker for IL-17F in intestinal sections from 
subjects with ulcerative colitis (UC, n = 17), polyp (n = 7) and colorectal cancer (CRC, 
n = 29) (original magnification x 10 and 20, Arrows representing positive staining).  
B: Quantitative analysis of IL-17F positive area of intestinal sections (% of whole 
sections). C：The staining with the marker for IL-17RB in intestinal sections from UC, 
polyp and CRC (original magnification x 10 and 20, Arrows representing positive 
staining). D: Quantitative analysis of IL-17RC positive area of intestinal sections (% 
of whole sections). Data are expressed as the mean ± SEM.  
 
Figure. 4. Infiltration of CD3+ T cells and CD68+ macrophages in UC, polyp and 
CRC tissues. A and C: Representative immunohistochemistry images of CD3+ 
lymphocytes and CD68+ macrophages in intestinal sections from subjects with 
ulcerative colitis (UC, n = 17), polyp (n = 7) and colorectal cancer (CRC, n = 29) 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 27 
(original magnification x 10 and 20, Arrows representing positive cells). B and D: 
Quantitative analysis of numbers of CD3+ T cells and CD68+ macrophages per unit 
area of intestinal sections. Data are expressed as the mean ±SEM.  
 
Figure. 5. Infiltration of elastase+ neutrophils and tryptase+ mast cells in UC, 
polyp and CRC tissues. A and C: Representative immunohistochemistry images of 
elastase+ neutrophils and tryptase+ mast cells in intestinal sections from subjects with 
ulcerative colitis (UC, n = 17), polyp (n = 7) and colorectal cancer (CRC, n = 29) 
(original magnification x 10 and 20, Arrows representing positive cells). B and D: 
Quantitative analysis of numbers of elastase+ neutrophils and tryptase+ mast cells per 
unit area of intestinal sections. Data are expressed as the mean ± SEM.  
 
Figure. 6. Expression for CD90+ fibroblasts and CD31+ blood vessels in UC, 
polyp and CRC tissues. A and C: Representative immunohistochemistry images of 
CD31+ blood vessels and CD90+ fibroblasts with ulcerative colitis (UC, n = 17), polyp 
(n = 7) and colorectal cancer (CRC, n = 29) (original magnification x 10 and 20, 
Arrows representing positive cells). B: Representative immunohistochemistry images 
and quantitative analysis of numbers of CD31+ blood vessels in intestinal sections. D: 
Quantitative analysis of CD90+ fibroblast positive area of intestinal sections (% of 
whole sections). Data are expressed as the mean ± SEM.  
 
Figure. 7. Correlations between IL-17A, IL-17RA and CD68+ macrophages in 
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CRC. A: There existed obvious positive correlation between IL-17A and IL-17RA. B: 
Positive correlation was found between IL-17A expression and infiltration of CD68+ 
macrophages. C: Positive correlation was found between IL-17RA expression and 
infiltration of CD68+ macrophages.  
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Table 1 
Clinical characteristics of the subjects 
Status  Age (median) Sources Pathological  
characteristics  
Differentiation 
grade 
Ulcerative 
colitis 
(UC) 
n=17 
 
52.8 (32-75) 
Male 13 
Female 4 
Endoscopic biopsies    
 
Polyp  
n=7 
 
54.3(22-84) 
Male 6 
Female 1 
 
Endoscopic biopsies 
or resection 
specimens  
 
Hyperplastic 
polyp 
 
Colorectal 
cancer 
(CRC)   
n=29 
 
64.5 (43-83) 
Male 24 
Female 5 
 
Endoscopic biopsies 
or resection 
specimens 
 
Adenocarcinoma                 
 
High (n=8)
Middle (n=17) 
Low (n=4) 
 
Table 2   
Relative antibodies used in this research 
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  Antibody Item number Isotype Dilution Sources 
Anti-IL-17A NBP1-42746 Rabbit-IgG 1:300 Novus iologicals（USA） 
Anti-IL-17E NB100-56541  Mouse-IgG1 1:4000 Novus Biologicals
（USA） 
Anti-IL-17F NBP2-21684 Mouse-IgG1 1:1000 Novus Biologicals
（USA） 
Anti-IL-17RA ab133416 Goat-IgG 1:200 Abcam (Hong Kong) Ltd
（China） 
Anti-IL-17RB NBP1-39952 Mouse-IgG1 1:200 Novus Biologicals（USA） 
Anti-IL-17RC NBP1-83112 Rabbit-IgG 1:50 Novus Biologicals（USA） 
PECAM-1
（Anti-CD31） 
SC-53411 Mouse-IgG1 1:20 Santa Cruz Inc（USA） 
Anti-CD90/Thy1 NBP1-42068 Rabbit-IgG 1:100 Novus Biologicals（USA） 
Anti-CD3      ab699 Mouse-IgG2a 1:20 Abcam (Hong Kong) Ltd
（China） 
Anti-CD68 sc-70761 Mouse-IgG 1:800 Santa Cruz Inc（USA） 
Anti-Neutrophil 
Elastase  
Ab21595 Rabbit-IgG 1:800 Abcam (Hong Kong) Ltd
（China） 
Anti-Mast Cell 
Tryptase 
Ab64192 Rabbit-IgG 1:2000 Abcam Ltd（USA） 
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